A Clinical Study of the Pharmacokinetics and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin
Clinical trial NCT06112808 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06112808
- Sponsor
- Biocad
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-29
- Primary completion
- 2024-01-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.